So, why stop there? The next terrifying chapter in the book of bubbles is on biotech stocks. These are the companies that spend much of their time in labs working on drugs and other medical ...

Rubius Therapeutics, a preclinical biotech developing novel therapies based on red blood cells, filed on Friday with the SEC to raise up to $200 million in an initial public offering. The ...

In a recent update, PharmAla Biotech disclosed the termination of its contract with Red Light Holland (OTC:TRUFF), a partnership that officially ended on September 3, 2024. While the company did ...

Like many biotech startups, Red Queen is tiny, with seven full-time employees and up to two dozen consultants, said Mitchnick. Apple Tree has founded several biotechs in Massachusetts, including ...

After the Rubius scientists genetically engineer the red cells, they can be grown in bioreactors, the stainless steel tanks used to produce biotech drugs. “We are basically using a manufacturing ...